Condition
Schizophrenia and Predominant Negative Symptoms clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Schizophrenia and Predominant Negative Symptoms clinical trials that are recruiting, at sites in 2 countries (most in Israel (1), Canada (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Combination of Deferiprone and N-Acetylcysteine for Negative Symptoms in Schizophrenia
This study tests whether adding deferiprone and NAC to the usual antipsychotic treatment can help people with schizophrenia or schizoaffective disorder who have prominent negative symptoms.
-
Accelerated brain stimulation to reduce negative symptoms of schizophrenia
This will test whether a fast course of noninvasive brain stimulation given over five days can help people with schizophrenia who have marked negative symptoms like low motivation and reduced emotional expression.
Related topics
Quick answers
How many Schizophrenia and Predominant Negative Symptoms clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Israel (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.